Mordecai P Blaustein Selected Research

Ouabain (G Strophanthin)

1/2018	Central and peripheral slow-pressor mechanisms contributing to Angiotensin II-salt hypertension in rats.
1/2018	The pump, the exchanger, and the holy spirit: origins and 40-year evolution of ideas about the ouabain-Na+ pump endocrine system.
11/2017	How does pressure overload cause cardiac hypertrophy and dysfunction? High-ouabain affinity cardiac Na+ pumps are crucial.
11/2016	Pivotal role of α2 Na+ pumps and their high affinity ouabain binding site in cardiovascular health and disease.
3/2014	Ouabain-digoxin antagonism in rat arteries and neurones.
1/2014	Neuroendocrine humoral and vascular components in the pressor pathway for brain angiotensin II: a new axis in long term blood pressure control.
1/2013	Salt sensitivity, endogenous ouabain and hypertension.
10/2012	Nanomolar ouabain increases NCX1 expression and enhances Ca2+ signaling in human arterial myocytes: a mechanism that links salt to increased vascular resistance?
12/2010	Signaling mechanisms that link salt retention to hypertension: endogenous ouabain, the Na(+) pump, the Na(+)/Ca(2+) exchanger and TRPC proteins.
1/2010	Upregulation of Na+ and Ca2+ transporters in arterial smooth muscle from ouabain-induced hypertensive rats.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mordecai P Blaustein Research Topics

Disease

23	Hypertension (High Blood Pressure) 01/2018 - 11/2004
2	Heart Failure 01/2018 - 03/2003
2	Essential Hypertension 01/2013 - 03/2006
1	Cardiomegaly (Heart Hypertrophy) 11/2017
1	Hypertrophy 11/2017
1	Reperfusion Injury 09/2007
1	Cardiac Arrhythmias (Arrythmia) 09/2007

Drug/Important Bio-Agent (IBA)

17	Ouabain (G Strophanthin)IBA 01/2018 - 11/2005
14	SaltsIBA 01/2018 - 11/2004
4	Digoxin (Digitek)FDA LinkGeneric 01/2018 - 03/2003
4	Proteins (Proteins, Gene)FDA Link 01/2014 - 12/2010
4	SodiumIBA 01/2013 - 03/2006
3	AldosteroneIBA 01/2018 - 03/2006
3	Sodium-Calcium ExchangerIBA 01/2014 - 11/2004
2	Hormones (Hormone)IBA 01/2018 - 12/2010
2	CalciumIBA 01/2014 - 09/2007
2	TRPC6 Cation ChannelIBA 01/2014 - 01/2013
2	hydroxide ionIBA 01/2010 - 09/2009
1	Cardiac GlycosidesIBA 01/2018
1	Natriuretic AgentsIBA 01/2018
1	Angiotensin IIIBA 01/2018
1	cardiac glycoside receptorsIBA 11/2017
1	Adenosine Triphosphatases (ATPase)IBA 03/2014
1	rostafuroxinIBA 03/2014
1	DigoxigeninIBA 03/2014
1	Carrier Proteins (Binding Protein)IBA 01/2014
1	Sarcoplasmic Reticulum Calcium-Transporting ATPasesIBA 01/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2012
1	adducinIBA 02/2012
1	Vasoconstrictor AgentsIBA 02/2012
1	Antihypertensive Agents (Antihypertensives)IBA 12/2010
1	CardenolidesIBA 12/2010
1	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2010
1	CollagenIBA 09/2009
1	Endothelium-Dependent Relaxing Factors (Endothelium Derived Relaxing Factor)IBA 01/2009
1	SteroidsIBA 03/2006
1	SEA 0400IBA 11/2004